Needham initiated coverage of Waystar (WAY) with a Buy rating and $46 price target The firm believes the company is well positioned to gain share in the “highly complex and inefficient” revenue cycle management industry. Waystar offers “differentiated end-to-end RCM” platform to health systems trying to recover lost revenue, the analyst tells investors in a research note. Needham sees an attractive entry point at current share levelsl.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAY:
- Waystar price target raised to $49 from $47 at Citi
- Waystar’s Earnings Call: Growth and Innovation Shine
- Waystar price target raised to $52 from $49 at BofA
- Waystar Holding Corp. Receives Buy Rating Amid Strong Financial Performance and Strategic Advancements
- Waystar price target raised to $50 from $48 at Mizuho